BioTech startup Synthace gets £7.3m Series A

Sep 20, 2017 · uktech.news

BioTech firm Synthace has raised £7.3m in Series A funding from investors including White Cloud Capital, Amadeus Capital Partners and Eleven Two Capital.

Existing shareholders Sofinnova Partners, SOSV and Bioeconony Capital also participated.

The company, which has created proprietary language and software platform Antha specifically for biologists, says it will use the cash to gain further traction and expand in the market.

Antha, the company says, is designed to make reproducible and scalable workflows that can be readily edited and shared, and easily automated on labs’ existing equipment.

Synthace CEO Tim Fell said: "Our need to heal, feed, fuel and manufacture for a growing population can be met by unlocking the near infinite power of biology but only by bringing software abstraction and more automation to biological R&D and manufacturing, and by enabling biologists to build atop their collective work. That is what the Antha platform does, and why we are so passionate about realizing its potential."

Read Complete Article

RT @benchisell: Excited for our mission to @money2020 - come drop by stand 1261 to talk about London/Starling. @L_Pbusiness @GotoGrow_Londo…

If you could see London’s air, you’d want to clean it too. Find out what I’m doing about it #CleanAir… https://t.co/T9QTY98t7u

RT @L_Pbusiness: London’s fintech sector has received more investment than any other major European city #Money2020 #LondonIsOpen https://t…

RT @TheSTMagazine: Tomorrow: a world exclusive interview with Bowe Bergdahl, the US solider tortured by the Taliban, then vilified by his o…

RT @MichelRouxOBE: Don't forget to pick up @SundayTimesFood tomorrow for more recipes from my new book CHEESE... https://t.co/olxYZPn8yr

Tech.London Weekly

×